The global inhalable drugs market is expected to experience significant growth in the coming years, fueled by the increasing prevalence of respiratory diseases like asthma and COPD, as well as the rising use of inhalable medications for managing diabetes and Parkinson’s disease. This market analysis explores key trends, drivers, and challenges shaping this sector.